Premium
Pharmacological therapies for the treatment of osteoarthritis
Author(s) -
McColl Geoffrey J
Publication year - 2001
Publication title -
medical journal of australia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.904
H-Index - 131
eISSN - 1326-5377
pISSN - 0025-729X
DOI - 10.5694/j.1326-5377.2001.tb143845.x
Subject(s) - medicine , osteoarthritis , drug , disease , pharmacotherapy , intensive care medicine , pharmacology , alternative medicine , pathology
SUMMARY Non‐pharmacological interventions are the first‐line therapy for osteoarthritis. If non‐pharmacological therapy fails, paracetamol (up to 4 g daily) should be added. If paracetamol fails, the patient's risk factors for gastrointestinal and renal disease should be assessed. In patients with gastrointestinal risk factors, a COX‐2‐specific inhibitor (CSI) would be used in preference to a conventional non‐steroidal anti‐inflammatory drug (NSAID). In patients with renal risk factors, NSAIDs and CSIs should be used with care. In patients who continue to have problems, other treatments should be considered; these might include intra‐articular hyaluronan or depot corticosteroid, analgesia or glucosamine.